{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:21:07Z","timestamp":1791105667023,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.biopsych.2006.06.038","type":"journal-article","created":{"date-parts":[[2006,9,2]],"date-time":"2006-09-02T11:22:12Z","timestamp":1157196132000},"page":"836-844","source":"Crossref","is-referenced-by-count":78,"title":["Enhanced Preproenkephalin-B\u2013Derived Opioid Transmission in Striatum and Subthalamic Nucleus Converges Upon Globus Pallidus Internalis in L-3,4-dihydroxyphenylalanine\u2013Induced Dyskinesia"],"prefix":"10.1016","volume":"61","author":[{"given":"Incarnation","family":"Aubert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Guigoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Dovero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard H.","family":"Bioulac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian E.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan R.","family":"Crossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Bloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwan","family":"Bezard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2006.06.038_bib1","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/0166-2236(90)90107-L","article-title":"Functional architecture of basal ganglia circuits: Neural substrates of parallel processing","volume":"13","author":"Alexander","year":"1990","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.biopsych.2006.06.038_bib2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/(SICI)1096-9861(20000228)418:1<22::AID-CNE2>3.0.CO;2-Q","article-title":"Phenotypical characterization of the neurons expressing the D1 and D2 dopamine receptors in the monkey striatum","volume":"418","author":"Aubert","year":"2000","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.biopsych.2006.06.038_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.20296","article-title":"Increased D(1) dopamine receptor signaling in levodopa-induced dyskinesia","volume":"57","author":"Aubert","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biopsych.2006.06.038_bib4","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/377424a0","article-title":"Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors","volume":"377","author":"Baik","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2006.06.038_bib5","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.1523\/JNEUROSCI.18-14-05301.1998","article-title":"A complex program of striatal gene expression induced by dopaminergic stimulation","volume":"18","author":"Berke","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2006.06.038_bib6","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/35086062","article-title":"Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies","volume":"2","author":"Bezard","year":"2001","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.biopsych.2006.06.038_bib7","doi-asserted-by":"crossref","first-page":"10999","DOI":"10.1523\/JNEUROSCI.23-35-10999.2003","article-title":"Enriched environment confers resistance to MPTP and cocaine: Involvement of dopamine transporter and neurotrophic factors","volume":"23","author":"Bezard","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2006.06.038_bib8","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.1523\/JNEUROSCI.21-17-06853.2001","article-title":"Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive MPTP-lesioned macaque model of Parkinson\u2019s disease","volume":"21","author":"Bezard","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2006.06.038_bib9","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nm875","article-title":"Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function","volume":"9","author":"Bezard","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.biopsych.2006.06.038_bib10","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.nbd.2004.10.005","article-title":"L-DOPA reverses the MPTP-induced elevation of the arrestin2 and GRK6 expression and enhanced ERK activation in monkey brain","volume":"18","author":"Bezard","year":"2005","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.biopsych.2006.06.038_bib11","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/brain\/124.3.546","article-title":"Dopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alteration of pallidal neurons in the MPTP-treated monkey","volume":"124","author":"Boraud","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.biopsych.2006.06.038_bib12","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/jnen\/61.2.186","article-title":"Increase of preproenkephalin mRNA levels in the putamen of Parkinson disease patients with levodopa-induced dyskinesias","volume":"61","author":"Calon","year":"2002","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.biopsych.2006.06.038_bib13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00726-001-0116-4","article-title":"Transcription factors involved in the pathogenesis of L-DOPA-induced dyskinesia in a rat model of Parkinson\u2019s disease","volume":"23","author":"Cenci","year":"2002","journal-title":"Amino Acids"},{"key":"10.1016\/j.biopsych.2006.06.038_bib14","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1046\/j.1460-9568.1998.00285.x","article-title":"L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA","volume":"10","author":"Cenci","year":"1998","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.biopsych.2006.06.038_bib15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/exnr.1997.6771","article-title":"Topographical organization of opioid peptide precursor gene expression following repeated apomorphine treatment in the 6-hydroxydopamine-lesioned rat","volume":"150","author":"Duty","year":"1998","journal-title":"Exp Neurol"},{"key":"10.1016\/j.biopsych.2006.06.038_bib16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0006-8993(92)90716-M","article-title":"Dopaminergic modulation of striatal neuropeptides: Differential effects of D1 and D2 receptor stimulation on somatostatin, neuropeptide Y, neurotensin, dynorphin and enkephalin","volume":"581","author":"Engber","year":"1992","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2006.06.038_bib17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0306-4522(94)90061-2","article-title":"Neurotensin, substance P, delta and mu opioid receptors are decreased in basal ganglia of Parkinson\u2019s disease patients","volume":"61","author":"Fernandez","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2006.06.038_bib18","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/mds.10693","article-title":"Non-subtype-selective opioid receptor antagonism in treatment of levodopa-induced motor complications in Parkinson\u2019s disease","volume":"19","author":"Fox","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.biopsych.2006.06.038_bib19","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/S1471-1931(00)00019-7","article-title":"Molecular effects of dopamine on striatal-projection pathways","volume":"23","author":"Gerfen","year":"2000","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.biopsych.2006.06.038_bib20","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1126\/science.2147780","article-title":"D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons","volume":"250","author":"Gerfen","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2006.06.038_bib21","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1523\/JNEUROSCI.11-04-01016.1991","article-title":"Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: In situ hybridization histochemical analysis","volume":"11","author":"Gerfen","year":"1991","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2006.06.038_bib22","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1460-9568.2005.04196.x","article-title":"Levodopa-induced dyskinesia in MPTP-treated macaque is not dependent of the extent and pattern of the nigrostrial lesion","volume":"22","author":"Guigoni","year":"2005","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.biopsych.2006.06.038_bib23","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1523\/JNEUROSCI.5059-04.2005","article-title":"Involvement of sensorimotor, limbic, and association basal ganglia domains in levodopa-induced dyskinesia","volume":"28","author":"Guigoni","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2006.06.038_bib24","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1006\/exnr.1998.6996","article-title":"Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat","volume":"155","author":"Henry","year":"1999","journal-title":"Exp Neurol"},{"key":"10.1016\/j.biopsych.2006.06.038_bib25","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0014-4886(03)00064-5","article-title":"Increased striatal pre-proenkephalin B expression is associated with dyskinesia in Parkinson\u2019s disease","volume":"183","author":"Henry","year":"2003","journal-title":"Exp Neurol"},{"key":"10.1016\/j.biopsych.2006.06.038_bib26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1006\/exnr.2001.7727","article-title":"mu- and delta-Opioid receptor antagonists reduce levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson\u2019s Disease","volume":"171","author":"Henry","year":"2001","journal-title":"Exp Neurol"},{"key":"10.1016\/j.biopsych.2006.06.038_bib27","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0306-4522(95)00120-8","article-title":"Effects of L-Dopa on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatum","volume":"68","author":"Herrero","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2006.06.038_bib28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1146\/annurev.pa.26.040186.000423","article-title":"Opioid peptide processing and receptor selectivity","volume":"26","author":"Hollt","year":"1986","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.biopsych.2006.06.038_bib29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0306-4522(01)00565-6","article-title":"Further characterization of preproenkephalin mRNA-containing cells in the rodent globus pallidus","volume":"111","author":"Hoover","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2006.06.038_bib30","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/306611a0","article-title":"Isolation and structural organization of the human preproenkephalin B gene","volume":"306","author":"Horikawa","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2006.06.038_bib31","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/ana.410420513","article-title":"Effects of apomorphine on Globus Pallidus neurons in parkinsonian patients","volume":"42","author":"Hutchinson","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biopsych.2006.06.038_bib32","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1006\/nbdi.2000.0372","article-title":"Alterations in cortical and basal ganglia levels of opioid receptor binding in a rat model of L-dopa\u2013induced dyskinesia","volume":"8","author":"Johansson","year":"2001","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.biopsych.2006.06.038_bib33","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1146\/annurev.pharmtox.40.1.389","article-title":"Molecular mechanisms and regulation of opioid receptor signaling","volume":"40","author":"Law","year":"2000","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.biopsych.2006.06.038_bib34","first-page":"301","article-title":"Quantitative in situ hybridization using radioactive probes in the study of gene expression in heterocellular systems","volume":"33","author":"Le Moine","year":"1994","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.biopsych.2006.06.038_bib35","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/cne.903500307","article-title":"Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study","volume":"350","author":"Mansour","year":"1994","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.biopsych.2006.06.038_bib36","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0006-8993(95)00928-J","article-title":"The cloned mu, delta and kappa receptors and their endogenous ligands: Evidence for two opioid peptide recognition cores","volume":"700","author":"Mansour","year":"1995","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2006.06.038_bib37","doi-asserted-by":"crossref","first-page":"22795","DOI":"10.1074\/jbc.M300084200","article-title":"Differential sorting of human delta-opioid receptors after internalization by peptide and alkaloid agonists","volume":"278","author":"Marie","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopsych.2006.06.038_bib38","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/(SICI)1096-9861(19970728)384:2<211::AID-CNE4>3.0.CO;2-4","article-title":"In situ hybridization histochemical localization of prodynorphin messenger RNA in the central nervous system of the rat","volume":"384","author":"Merchenthaler","year":"1997","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.biopsych.2006.06.038_bib39","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0169-328X(97)00123-X","article-title":"Preproenkephalin mRNA expression in the caudate-putamen of MPTP monkeys after chronic treatment with the D2 agonist U91356A in continuous or intermittent mode of administration: comparison with L-Dopa therapy","volume":"49","author":"Morissette","year":"1997","journal-title":"Mol Brain Res"},{"key":"10.1016\/j.biopsych.2006.06.038_bib40","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1046\/j.1471-4159.1999.0720682.x","article-title":"Differential regulation of striatal preproenkephalin and preprotachykinin mRNA levels in MPTP-lesioned monkeys chronically treated with dopamine D-1 or D-2 receptor agonists","volume":"72","author":"Morissette","year":"1999","journal-title":"J Neurochem"},{"key":"10.1016\/j.biopsych.2006.06.038_bib41","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0168-0102(02)00027-5","article-title":"Functional significance of the cortico-subthalamo-pallidal \u2019hyperdirect\u2019 pathway","volume":"43","author":"Nambu","year":"2002","journal-title":"Neurosci Res"},{"key":"10.1016\/j.biopsych.2006.06.038_bib42","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0306-4522(94)00606-6","article-title":"Preproenkephalin and preprotatachykinin messenger RNA expression in normal basal ganglia and in Parkinson\u2019s disease","volume":"66","author":"Nisbet","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2006.06.038_bib43","first-page":"S22","article-title":"Pathophysiology of levodopa-induced dyskinesias in Parkinson\u2019s disease: Problems with the current model","volume":"47","author":"Obeso","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biopsych.2006.06.038_bib44","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/1531-8249(199911)46:5<732::AID-ANA8>3.0.CO;2-Q","article-title":"Internal globus pallidus discharge is nearly suppressed during levodopa-induced dyskinesias","volume":"46","author":"Papa","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biopsych.2006.06.038_bib45","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/ana.410420508","article-title":"Alterations in opioid receptor binding in Parkinson\u2019s disease patients with levodopa-induced dyskinesias","volume":"42","author":"Piccini","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biopsych.2006.06.038_bib46","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/mds.870090410","article-title":"Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson\u2019s disease","volume":"9","author":"Rascol","year":"1994","journal-title":"Mov Disord"},{"key":"10.1016\/j.biopsych.2006.06.038_bib47","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.lfs.2004.10.024","article-title":"Basal opioid receptor activity, neutral antagonists, and therapeutic opportunities","volume":"76","author":"Sadee","year":"2005","journal-title":"Life Sci"},{"key":"10.1016\/j.biopsych.2006.06.038_bib48","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S0028-3908(03)00249-1","article-title":"Opioid antagonists increase the dyskinetic response to dopaminergic agents in parkinsonian monkeys: Interaction between dopamine and opioid systems","volume":"45","author":"Samadi","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2006.06.038_bib49","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/0196-9781(82)90067-5","article-title":"Endogenous ligands for kappa-opiate receptors","volume":"3","author":"Schulz","year":"1982","journal-title":"Peptides"},{"key":"10.1016\/j.biopsych.2006.06.038_bib50","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1210\/edrv-9-2-200","article-title":"The molecular basis of opioid receptor function","volume":"9","author":"Simonds","year":"1988","journal-title":"Endocr Rev"},{"key":"10.1016\/j.biopsych.2006.06.038_bib51","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/0306-4522(93)90309-4","article-title":"Long-term changes in striatal opioid systems after 6-hydroxydopamine lesion of rat substantia nigra","volume":"55","author":"Smith","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2006.06.038_bib52","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejpain.2004.07.010","article-title":"What to learn from in vivo opioidergic brain imaging?","volume":"9","author":"Sprenger","year":"2005","journal-title":"Eur J Pain"},{"key":"10.1016\/j.biopsych.2006.06.038_bib53","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0306-4522(02)00535-3","article-title":"Alterations in striatal neuropeptide mRNA produced by repeated administration of L-DOPA, ropinirole or bromocriptine correlate with dyskinesia induction in MPTP-treated common marmosets","volume":"115","author":"Tel","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2006.06.038_bib54","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1046\/j.0953-816x.2001.01743.x","article-title":"Persistent changes in striatal gene expression induced by long-term L-DOPA treatment in a rat model of Parkinson\u2019s disease","volume":"14","author":"Westin","year":"2001","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.biopsych.2006.06.038_bib55","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1006\/nbdi.2002.0499","article-title":"L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of Parkinson\u2019s disease: Relation to motor and cellular parameters of nigrostriatal function","volume":"10","author":"Winkler","year":"2002","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.biopsych.2006.06.038_bib56","first-page":"56","article-title":"L-Dopa: Its clinical effects in parkinsonism","volume":"93","author":"Yahr","year":"1968","journal-title":"Trans Amer Neurol Ass"},{"key":"10.1016\/j.biopsych.2006.06.038_bib57","doi-asserted-by":"crossref","first-page":"14301","DOI":"10.1016\/S0021-9258(18)89893-3","article-title":"Rat brain preproenkephalin mRNA. cDNA cloning, primary structure, and distribution in the central nervous system","volume":"259","author":"Yoshikawa","year":"1984","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopsych.2006.06.038_bib58","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1046\/j.1460-9568.2000.00988.x","article-title":"Alterations in preproenkephalin and adenosine-2a receptor mRNA, but not preprotachykinin mRNA correlate with occurrence of dyskinesia in normal monkeys chronically treated with L-DOPA","volume":"12","author":"Zeng","year":"2000","journal-title":"Eur J Neurosci"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322306008699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322306008699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T02:30:36Z","timestamp":1627785036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322306008699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":58,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S0006322306008699"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2006.06.038","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}